Abiopharma

New Form 4/A - Adaptive Biotechnologies Corp Filed: 2026-01-07 AccNo: 0001780660-26-000002 Size: 17 KB

Director ROBINS CHAD M 🔴 sold 125.0K shares of Adaptive Biotechnologies Corp (ADPT) at $15.59 ($1.9M) Transaction Date: Jan 05, 2026 | Filing ID: 000001

Avanos Medical, Inc. to Present at the 44th Annual J.P. Morgan Healthcare Conference

Director Resnick Joshua 🔴 sold 27.3K shares (2 derivative) of Cidara Therapeutics, Inc. (CDTX) at $26.62 Transaction Date: Jan 07, 2026 | Filing ID: 000002

Director Spencer Ryan 🔴 sold 17.5K shares (3 derivative) of Cidara Therapeutics, Inc. (CDTX) at $21.31 Transaction Date: Jan 07, 2026 | Filing ID: 000002

Director Merson James 🔴 sold 17.5K shares (3 derivative) of Cidara Therapeutics, Inc. (CDTX) at $21.31 Transaction Date: Jan 07, 2026 | Filing ID: 000002

Director Canale-Theakston Carin 🔴 sold 35.4K shares (7 derivative) of Cidara Therapeutics, Inc. (CDTX) at $50.20 Transaction Date: Jan 07, 2026 | Filing ID: 000002

Kodiak Sciences to Present at 44th Annual J.P. Morgan Healthcare Conference

Kodiak Sciences to Present at 44th Annual J.P. Morgan Healthcare Conference

Director Mineo Chrysa 🔴 sold 42.9K shares (10 derivative) of Cidara Therapeutics, Inc. (CDTX) at $221.50 ($1.8M) Transaction Date: Jan 07, 2026 | Filing ID: 000002

Director Schroeder Theodore R 🔴 sold 41.1K shares (11 derivative) of Cidara Therapeutics, Inc. (CDTX) at $204.40 ($1.1M) Transaction Date: Jan 07, 2026 | Filing ID: 000003

Director BURGESS DANIEL D 🔴 sold 41.2K shares (11 derivative) of Cidara Therapeutics, Inc. (CDTX) at $221.50 ($1.2M) Transaction Date: Jan 07, 2026 | Filing ID: 000002

Director Stein Jeffrey 🔴 sold 1.1M shares (11 derivative) of Cidara Therapeutics, Inc. (CDTX) at $221.50 ($37.2M) Transaction Date: Jan 07, 2026 | Filing ID: 000005

KARBE FRANK 🔴 sold 165.7K shares (1 derivative) of Cidara Therapeutics, Inc. (CDTX) at $221.50 ($4.0M) Transaction Date: Jan 07, 2026 | Filing ID: 000002

Day Lucy 🔴 sold 8.8K shares of AN2 Therapeutics, Inc. (ANTX) at $1.01 Transaction Date: Jan 05, 2026 | Filing ID: 006771